InvestorsHub Logo
Followers 120
Posts 20756
Boards Moderated 0
Alias Born 06/13/2011

Re: sts66 post# 35435

Friday, 09/26/2014 10:15:33 PM

Friday, September 26, 2014 10:15:33 PM

Post# of 426487
STS

I have always wondered ..can Anchor be resubmitted for a far narrower patient group .

Example ...my lipid disorder ..hetero FH ...we have to avoid anything that may raise LDL cholesterol ...so obviously we never are prescribed Lovaza ( as far as I know ) ...but Vascepa is an ideal way for us to lower TG's beyond what we achieve with Statins

Or is this really ..no matter what ...the FDA wants Outcome data ...end of story
Wondering what your opinion is
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News